Evidence map›Paper›PMID 36183079›Full record

ArticleBMC health services research2022

Rational design of an essential diagnostics network to support Universal Health Coverage: a modeling analysis.

Lee F Schroeder, Yvonne Dei-Adomakoh, Kristen DeStigter, Emmanuel O Idigbe, John Flanigan, Priscilla Mawuli Awo Ekpale, Ernest Adjei, Lina Roa, Michael L Wilson, Susan Horton

Abstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lee F SchroederDepartment of Pathology & Clinical Labs, University of Michigan Medical School, NCRC, Bldg. 35, 2800 Plymouth Road, Ann Arbor, MI, 48109-2800, USA. leeschro@med.umich.edu.ORCID http://orcid.org/0000-0002-2787-3608
Yvonne Dei-AdomakohDepartment of Haematology, University of Ghana Medical School, Accra, Ghana.
Kristen DeStigterUniversity of Vermont Larner College of Medicine, Vermont, USA.
Emmanuel O IdigbeHuman Development and Public Health Initiative, Lagos, Nigeria.
John FlaniganNational Cancer Institute, Bethesda, MD, USA.
Priscilla Mawuli Awo EkpaleDepartment of Pharmacy, Korle Bu Teaching Hospital, Accra, Ghana.
Ernest AdjeiDepartment of Pathology, Komfo Anokye Teaching Hospital, Kumasi, Ghana.
Lina RoaDepartment of Obstetrics and Gynecology, University of Alberta, Edmonton, Canada.
Michael L WilsonDenver Health and Hospital Authority, Denver, CO, USA.
Susan HortonSchool of Public Health Sciences, University of Waterloo, Waterloo, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnostic investigations, including pathology and laboratory medicine (PALM) and radiology, have been largely absent from international strategies such as the Sustainable Development Goals. Further, there is little international guidance on which health system tiers different diagnostics should be placed, a critical step in developing a country-level diagnostics network. We describe a modeling strategy to produce tier-specific diagnostic recommendations based on disease burden, current treatment pathways, and existing infrastructure in a country.

methodsThe relational model assumes that diagnostics should be available at the lowest tier where patients might receive medical management. Using Ghana as an exemplar, the 20 diseases forecasted by 2030 and 2040 to cause the greatest burden in low- and middle-income countries were mapped to three generalized tiers in the Ghanaian health system (Primary, Secondary, and Tertiary care) for three levels of each disease (triage, uncomplicated, and complicated). The lowest tier at which a diagnostic could potentially be placed was restricted by existing infrastructure, though placement still required there be a medical justification for the diagnostic at that tier.

resultsThe model recommended 111 unique diagnostic investigations with 17 at Primary tier, an additional 45 at Secondary tier and a further 49 at Tertiary tier. Estimated capital costs were $8,330 at Primary tier and between $571,000 to $777,000 at Secondary tier. Twenty-eight different laboratory tests were recommended as send-outs from Primary to Secondary tier, and twelve as send-outs to Tertiary tier.

conclusionsThis model provides a transparent framework within which countries can customize diagnostic planning to local disease priorities, health system patient treatment pathways, and infrastructural limitations to best support Universal Health Coverage.

Indexed as

Cost of IllnessUniversal Health InsuranceGhanaHumansLaboratoriesDiagnosticsEssential Diagnostics ListImagingLaboratoriesUniversal Health Coverage

Identifiers

PMID36183079
PMCPMC9526922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.